HCPCS to NDC

HCPCS Code “q5120” To NDC Mapping Options

“q5120” To NDC Crosswalk(s)

Source HCPCS Code Target NDC Code
Q5120
Inj, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg
61314-0866-01
ZIEXTENZO 6 MG/0.6 ML SYRIN
Detail Information
Relationship Start Date 04/01/2024
Relationship End Date 02/28/2026
Number Of Items In Ndc Package 0.6
Ndc Package Measure ML
Ndc Package Type SYRINGE
Route Of Administration SQ
Billing Units ML
Q5120
Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg
61314-0866-02
ZIEXTENZO 6 MG/0.6 ML SYRINGE
Detail Information
Relationship Start Date 07/01/2020
Relationship End Date 12/31/3999
Number Of Items In Ndc Package 0.6
Ndc Package Measure ML
Ndc Package Type SYRINGE
Route Of Administration SQ
Billing Units ML
Q5120
Inj pegfilgrastim-bmez 0.5mg
61314-0866-01
Ziextenzo
Detail Information
Relationship Start Date
Relationship End Date
Number Of Items In Ndc Package
Ndc Package Measure
Ndc Package Type
Route Of Administration
Billing Units
Q5120
Inj pegfilgrastim-bmez 0.5mg
61314-0866-02
Ziextenzo
Detail Information
Relationship Start Date
Relationship End Date
Number Of Items In Ndc Package
Ndc Package Measure
Ndc Package Type
Route Of Administration
Billing Units